Omnicell (OMCL)
(Delayed Data from NSDQ)
$42.94 USD
-1.12 (-2.54%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $42.93 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Brokerage Reports
0 items in cart
Omnicell, Inc. [OMCL]
Reports for Purchase
Showing records 21 - 40 ( 337 total )
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Provider: Zacks Investment Research
Analyst: Research Department
Company: Omnicell, Inc.
Industry: Medical Info Systems
Provider: Zacks Investment Research
Analyst: Research Department
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Provider: Zacks Investment Research
Analyst: Research Department
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Provider: Zacks Investment Research
Analyst: Research Department
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
3Q Beat, but Sizebale Guide Down as We Had Feared in our Recent DG
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Omnicell, Inc.
Industry: Medical Info Systems
Muted Outlook with Less Visibility into Recovery Keeps Us SW
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Provider: Zacks Investment Research
Analyst: Research Department
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Proprietary Healthcare - Credit Card Transaction Data
Provider: KeyBanc Capital Markets
Analyst: Research Department